Supply Chain

NHS Supply Chain Delivers 28 New Radiotherapy Machines
Management & Administration NHS Supply Chain Delivers 28 New Radiotherapy Machines

Imagine a world where a cancer diagnosis doesn't mean endless hospital visits or grueling waits for treatment—where cutting-edge technology steps in to make recovery faster and more precise. This vision is becoming a reality within the UK's National Health Service (NHS) as a groundbreaking

Blue Book 2025: Chinese Medtech Climbs the Value Curve
Management & Administration Blue Book 2025: Chinese Medtech Climbs the Value Curve

A crowded domestic arena, tighter pricing from centralized procurement, and a surge of installed capacity have converged to push Chinese medical device makers to reframe growth not as a volume race but as a brand-and-compliance contest in higher-value global niches. The latest data picture

NHS Supply Chain Shifts to Selective Procurement Strategy
Management & Administration NHS Supply Chain Shifts to Selective Procurement Strategy

In a transformative move that could redefine the landscape of medical technology procurement in the United Kingdom, NHS Supply Chain (NHSSC) has embarked on a strategic pivot toward a more selective framework for sourcing MedTech products, marking a significant departure from the traditional broad,

AdventHealth Tops Gartner Healthcare Supply Chain Ranking
Management & Administration AdventHealth Tops Gartner Healthcare Supply Chain Ranking

In a landscape where healthcare supply chains face unprecedented challenges, from rising costs to global trade volatility, one organization has emerged as a beacon of innovation and resilience. The latest annual ranking by a leading research and advisory firm has placed AdventHealth at the pinnacle

What Drives the PTFE Market Growth from 2025 to 2034?
Management & Administration What Drives the PTFE Market Growth from 2025 to 2034?

The Polytetrafluoroethylene (PTFE) market stands at a pivotal moment, with projections indicating a robust climb from USD 3.4 billion in 2025 to USD 5.7 billion by 2034, driven by a compound annual growth rate (CAGR) of 6%. Renowned for its exceptional qualities such as chemical resistance,

How Will Clinical Lab Tests Transform Healthcare by 2034?
Management & Administration How Will Clinical Lab Tests Transform Healthcare by 2034?

Imagine a future where a simple blood test at home could predict a life-threatening condition years before symptoms appear, or where a quick diagnostic panel in a doctor’s office tailors a cancer treatment uniquely to a patient’s genetic makeup, revolutionizing personalized medicine. This vision is

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later